Table: Chugai Pharm -6-MTH group results (IFRS)

Chugai Pharmaceutical

26/07/2021 08:00

Jul 26 (Reuters)- 
              Chugai Pharmaceutical Co Ltd 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   6 months ended      6 months ended       Year to 
                  Jun 30, 2021        Jun 30, 2020     Dec 31, 2021 
                     LATEST             YEAR-AGO          COMPANY   
                     RESULTS             RESULT          FORECAST   
  Sales              390.23              368.12                     
                   (+6.0 pct)          (+14.9 pct)                  
  Operating          160.68              140.63                     
                   (+14.3 pct)         (+47.9 pct)                  
  Pretax
  Net                118.14              102.29                     
                   (+15.5 pct)         (+47.7 pct)                  
  EPS Basic         71.86 yen           62.26 yen                   
  EPS Diluted       71.81 yen           62.18 yen                   
  Ann Div                                                60.00 yen  
  -Q2 Div           30.00 yen           75.00 yen                   
  -Q4 Div                               30.00 yen        30.00 yen  
 
  NOTE - Chugai Pharmaceutical Co Ltd. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4519.T